The penetration of anti-infectives into the central nervous system

Neurologic Clinics

Volumn 17, Issue 4, 1999, Pages 883-900

  Kearney, B P ^a   Aweeka, F T ^a  

^a Building 100   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; FLUCONAZOLE; FOSCARNET; GENTAMICIN; IMIPENEM; ISONIAZID; NAFCILLIN; OFLOXACIN; PIPERACILLIN; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; STREPTOMYCIN; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; ZIDOVUDINE;

AREA UNDER THE CURVE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN INFECTION; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TRANSPORT; PRIORITY JOURNAL; REVIEW;

EID: 0032723696     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70171-7     Document Type: Article

References (92)

1. F. Aweeka A. Jayewardene S. Staprans Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex J Acquir Immune Defic Syndr Hum Retrovirol 20 1999 39
2. M. Barza L. Weinstein Pharmacokinetics of the penicillins in man Clin Pharmacol Ther 1 1976 297
3. O. Breuckner M. Alexander H. Collmann Tobramycin levels in cerebrospinal fluid of patients with slightly and severely impaired blood-cerebrospinal barrier Chemotherapy 27 1981 303
4. O. Breuckner M. Alexander F. Martens Gentamicin concentrations in cerebrospinal fluid of patients with inflamed and uninflamed meninges Infection 8 1980 86
5. O. Breuckner M. Trautmann D. Kolodziejczyk Netilmicin in human CSF after parenteral administration in patients with slightly and severely impaired blood CSF barriers J Antimicrob Chemother 11 1983 565
6. M.W. Brightman Ultrastructure of brain endothelium Bradbury M.W.B. Physiology and Pharmacology of the Blood-Brain Barrier 1992 Springer-Verlag New York 1 7
7. K. Brinkman F. Kroon P. Hugen Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients [letter] AIDS 12 1998 537
8. D. Burger C. Kraaijeveld P. Meemhorst Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV AIDS 7 1993 1581
9. N. Clumeck J. Thys vanHoof R. Amoxicillin entry into human cerebrospinal fluid: Comparison with ampicillin Antimicrob Agents Chemother 14 1978 531 532
10. J. Collins R. Dedrick Distributed Model for drug delivery to CSF and brain tissue Am J Physiol 243 1983 R303
11. P. Craven J. Graybill J. Jorgensen High-dose ketoconazole for treatment of fungal infections of the central nervous system Ann Intern Med 98 1983 160 167
12. C. Crone The blood-brain barrier: A modified tight epithelium Suckling A. Rumsby M. Bradbury M. The Blood-Brain Barrier in Health and Disease 1986 VCH New York 17 21
13. H.E. DeVries J. Kuiper A.G. DeBoer The blood-brain barrier in neuroinflammatory diseases Pharmacol Rev 49 1997 143
14. G. Dickinson D. Droller R. Greenman Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid Antimicrob Agents Chemother 20 1981 481
15. J. Dow J. Chazal A. Frydman Transfer kinetics of perfloxacin into the cerebro-spinal fluid after one hour IV infusion of 400 mg in man J Antimicrob Chemother 17 1986 81
16. M. Dudley R. Levitz R. Quintiliani Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges Antimicrob Agents Chemother 26 1984 811
17. R. Duma A. Berry S. Smith Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges Antimicrob Agents Chemother 26 1984 730 733
18. G. Ellard M. Humphries B. Allen Cerebrospinal fluid drug concentrations and the treatment of tuberculosis meningitis Am Rev Resp Dis 148 1993 650
19. G. Ellard M. Humphries M. Gabriel Penetration of pyrazinamide into the cerebrospinal fluid in tuberculosis meningitis BMJ 294 1987 284
20. A.J. Fischman N. Alpert E. Livni Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography Antimicrob Agents Chemother 37 1993 1270
21. A. Fojo K. Ueda D. Slamon Expression of a multidrug-resistance gene in human tumors and tissues Proc Nat Acad Sci U S A 84 1987 265
22. R. Forgan-Smith G. Ellard D. Newton Pyrazinamide and other drugs in tuberculosis meningitis Lancet II 1973 374
23. N. Foudraine R. Hoetelmans J. Lange Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine Lancet 351 1998 1547
24. I.R. Friedland K.P. Klugman Cerebrospinal fluid bactericidal activity against cephalosporin-resistant streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime Antimicrob Agents Chemother 41 1997 1888
25. U. Fuhr S. Harder S. Hafner CSF pharmacokinetics of ceftazadime in neurosurgical patients with an external ventriculostomy Infection 17 1989 15 16
26. D. Gerding L. Peterson Comparative tissue and extravascular fluid concentrations of ceftizoxime Antimicrob Agents Chemother 10 1982 105
27. Gisolf E, Portegies P, Hoetelmans R, et al: Effect of ritonavir (RTV)/saquinavir (SQV) versus RTC/SQV/stavudine (d4T) on cerebrospinal fluid (CSF) HIR-RNA levels: Preliminary results. Twelfth World AIDS Conference, Geneva, Switzerland, 1998
28. N. Greig Drug entry into the brain and its pharmacologic manipulation Bradbury M. Physiology and Pharmacology of the Blood-Brain Barrier 1992 Springer-Verlag New York 487 490
29. D.R. Groothuis R.M. Levy The entry of antiviral and antiretroviral drugs into the central nervous system J Neurovirol 3 1997 387
30. Haas D, Spearman P, Johnson B, et al: Discordant HIV-1 RNA decay in CSF versus plasma following initiation of antiretroviral therapy: A prospective ultraintensive CSF sampling study [abstract 404]. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, IL, 1999
31. N. Hartman R. Yarchoan J. Pluda Pharmacokinetics of 2′, 3′-dideoxyadenosine and 2′, 3′-dideoxyinosine in patients with severe human immunodeficiency virus infection Clin Pharmacol Ther 47 1990 647
32. S. Haworth B. Christofalo R. Anderson A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults J Acquir Immune Defc Synd Hum Retrovirol 17 1998 235
33. U. Hengge N. Brockmeyer R. Malessa Foscarnet penetrates the blood-brain barrier: Rationale for therapy of cytomegalovirus encephalitis Antimicrob Agents Chemother 37 1993 1010
34. R. Hoetelmans C. Kraaijeveld P. Meenhorst Penetration of 3′-amino-3′-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1 infected patients J Acquir Immune Defic Synd Hum Retrovirol 15 1997 131
35. R. Jacobs G. Kerns A. Brown Cerebrospinal fluid penetration of imipenem and cilastatin (Primaxin) in children with central nervous system infection Antimicrob Agents Chemother 29 1986 670
36. D. Kafetzis D. Brater A. Kapiki Treatment of severe nosocomial infections with cefotaxime J Pediatr 100 1982 483
37. A.B. Kaiser Z.A. McGee Aminoglycoside therapy of gram-negative bacillary meningitis N Engl J Med 293 1975 1215
38. S. Kaojarern K. Supmonchai P. Phuapradit Effects of steroids on cerebrospinal fluid penetration of antituberculosis drugs in tuberculosis meningitis Clin Pharmacol Ther 49 1991 6
39. Kearney B, Price R, Sheiner L, et al: Estimation of nevirapine exposure within cerebrospinal fluid using CSF:plasma area under the curve ratios [abstract 406]. Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 1999
40. R. Kim M. Fromm C. Wandel The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J Clin Invest 101 1998 289
41. R. Kitzes-Cohen A. Miller A. Giloba Penetration of ciprofloxacin into human cerebrospinal fluid Rev Infect Dis 10 1988 S256
42. R. Klecker J. Collins R. Yarchoan Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′deoxythymidine: A novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases Clin Pharmacol Ther 41 1987 407
43. O. Klein H. Neu Use of antimicrobial agents to treat central nervous system infection Neurosurg Clin N Am 3 1992 323
44. U. Kniesel W. Risau H. Wolburg Development of blood-brain barrier tight junctions Couraud P.-O. Scherman D. Biology and Physiology of the Blood-Brain Barrier: Transport, Cellular Interactions, and Brain Pathologies 1996 Plenum Publishing NY
45. Letendre S, Caparelli E, Ellis R, et al: Levels of serum and cerebrospinal fluid (CSF) indinavir (IND) and HIV RNA in HIV-infected individuals [abstract 407]. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, IL, 1999
46. M.S. Luer J. Hatton Vancomycin administration into the cerebrospinal fluid: A review Ann Pharmacother 27 1993 912
47. E. Martin J.R. Koup U. Paravicini Pharmacokinetics of ceftriaxone in neonates and infants with meningitis J Pediatr 105 1984 475
48. J. McClain J. Rhoads G. Krol Cerebrospinal fluid concentrations of ciprofloxacin in subjects with uninflamed meninges J Antimicrob Chemother 21 1988 808 809
49. J. Mohr W. Griffiths R. Jackson Neurosyphilis and penicillin levels in cerebrospinal fluid JAMA 236 1976 2208
50. H. Nakagawa M. Yamada K. Tokiyoshi Penetration of potassium clavulanate/ticaricillin sodium into cerebrospinal fluid in neurosurgical patients Jpn J Antibiot 47 1994 93
51. R. Nau K. Kinzig T. Dreyhaupt Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin Antimicrob Agents Chemother 38 1994 1849
52. R. Nau M. Kinzing-Schippers F. Sorgal Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients Antimicrob Agents Chemother 41 1997 987
53. R. Nau H. Prange M. Kinzig Cerebrospinal fluid ceftazadime kinetics in patients with external ventriculostomies Antimicrob Agents Chemother 40 1996 763
54. R. Nau H. Prange J. Martell Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges J Antimicrob Chemother 25 1990 965
55. R. Nau H. Prange P. Muth Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges Antimicrob Agents Chemother 37 1993 1518
56. R. Nau H.W. Prange S. Menck Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges J Antimicrob Chemother 29 1992 719
57. R. Nau P. Scholz S. Sharifi Netilmicin cerebrospinal fluid concentrations after an intravenous infusion of 400 mg in patients without meningeal inflammation J Antimicrob Chemother 32 1993 893
58. R. Nau F. Sorgel H.W. Prange Lipophilicity at pH 7.4 and molecular size govern the entry of the free fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges J Neurol Sci 122 1994 61
59. R. Nau F. Sorgel H.W. Prange Pharmacokinetic optimization of the treatment of bacterial central nervous system infections Clin Pharmacokinet 35 1998 223
60. A. Papastamelos A. Tunkel Antimicrobial agents in infections of the central nervous system and eye Infect Dis Clin North Am 9 1995 615
61. M. Parry H. Neu Ticarcillin for treatment of serious infections with gram-negative bacteria J Infect Dis 134 1976 476
62. Polis M, Yoder C, Mican J, et al: More than 2 months of an aggressive 4-drug antiretroviral regimen is required to suppress CSF HIV viral burden in previously antiretroviral naive patients [abstract 404]. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, IL, 1999
63. Polli J, Studenberg S, Jarrett J, et al: Effect of P-glycoprotein on the CNS disposition of amprenavir and HIV protease inhibitors. Annual Meeting of the American Association of Pharmaceutical Scientists, San Francisco, CA, 1998
64. Price R, Aweeka F, Bellibas S, et al: Pharmacokinetics of abacavir (1592U89) in cerebrospinal fluid (CSF) using multiple lumbar punctures of few subjects and “sparse sampling” techniques. Twelfth World AIDS Conference. Geneva, Switzerland, 1998.
65. A. Ristuccia J. LeFrock Cerebrospinal fluid penetration of antimicrobials Antibiot Chemother 45 1992 118 152
66. J. Rockowitz A. Tunkel Bacterial meningitis: Practical guidelines for management Drugs 50 1995 839
67. B. Rolinski J. Bogner I. Sadri Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients J Acquir Immune Defic Synd Hum Retrovirol 15 1997 192
68. L. Sathle C. Martin J. Svensson Indinavir in cerebrospinal fluid of HIV-1 infected patients [letter] Lancet 350 1997 1823
69. U. Schaad J. Nelson G. McCracken Pharmacology and efficacy of vancomycin for staphylococcal infections in children Rev Infect Dis 3 1981 S282
70. A. Schinkel Pharmacological insights from P-glycoprotein knockout mice Int J Clin Pharmacol Ther 36 1998 9
71. T. Schmidt M. Tauber Pharmacodynamics of antibiotics in the therapy of meningitis: Infection model observations J Antimicrob Chemother 31 1993 61
72. M. Segal The blood-CSF barrier and the choroid plexus Pardridge W.M. Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology 1998 Cambridge University Press New York 251 257
73. W. Shapiro Cerebrospinal fluid circulation and the blood-brain barrier Ann N Y Acad Sci 9 1988
74. F. Sharom The P-glycoprotein efflux pump: How does it transport drugs? J Membr Biol 160 1997 161
75. J. Sjolin N. Eriksson P. Arneborn Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans Antimicrob Agents Chemother 35 1991 2606
76. J. Sjovall S. Bergdahl G. Movin Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection Antimicrob Agents Chemother 33 1989 1023
77. R. Spector Advances in understanding the pharmacology of agents used to treat bacterial meningitis Pharmacology 41 1990 113
78. J. Stahl J. Croize M. Lefebvre Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis Infection 14 1986 S254
79. J. Stern B. Hartman P. Sharkey Oral fluconazole therapy for patients with acquired immune deficiency syndrome and cryptococcus: Experience with 22 patients Am J Med 85 1988 477
80. G. Stubner G. Weinrich U. Brands Study of the cerebrospinal fluid penetration of ofloxacin Infection 14 1986 S250
81. H. Stutman M. Marks E. Swabb Single dose pharmacokinetics of aztreonam Antimicrob Agents Chemother 26 1984 196 199
82. T. Tartaglione A. Collier R. Coombs Acquired immunodeficiency syndrome: Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy Arch Neurol 48 1991 695
83. K. Tashima Cerebrospinal fluid levels of antiretroviral medications: Abstract and commentary JAMA 280 1998 879 880
84. Tashima K, Caliendo A, Ahmad M, et al: Cerebrospinal fluid HIV-1 RNA levels and efavirenz concentrations in patients enrolled in clinical trials. Twelfth World AIDS Conference, Geneva, Switzerland, 1998
85. F. Thiebaut T. Tsuruo H. Hamada Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci U S A 84 1987 7735
86. A. Tsuji I. Tamai Blood-brain barrier transport of drugs Partridge W.M. Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology 1998 Cambridge University Press New York 238 245
87. J. Utz I. Garrizues M. Sande Therapy of cryptococcosis with a combination of flucytosine and amphotericin B J Infect Dis 132 1975 368
88. Washington C, Man MC, Moy T, et al: The disposition of [14C]saquinavir in normal and P-glycoprotein (P-GP) deficient mice and cultured cells [abstract PII-34]. Ninety-Ninth Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, New Orleans, LA, 1998
89. T. Wells J. Trang A. Brown Cefotaxime therapy of bacterial meningitis in children J Antimicrob Chemother 14 1984 181
90. M. Wolff L. Boutron E. Singlas Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis Antimicrob Agents Chemother 31 1987 899 902
91. Yazdanian M, Ratigan S, Joseph D: Nevirapine, a non-nucleoside RT inhibitor, readily permeates the blood brain barrier. Fourth Conference on Retroviruses and Opportunistic Infections, 1997, Washington, DC
92. R. Yogev W. Schultz S. Rosenman Penetrance of nafcillin into human ventricular fluid: Correlation with ventricular pleocytosis and glucose levels Antimicrob Agents Chemother 19 1981 545